The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.

At this years 2023 conference we will have 50+ speakers and co-chairs touching on subjects like Practice Perspectives on the Enhancing Oncology Model, Federal and state policies to curb PBM bad behavior, Integrative medicine in cancer and much more.

After you browse the speakers and faculty, check out the where they all fall in the agenda!

Our Dynamic Keynote Speaker

Our Dynamic Keynote Speaker

Will Flanary, MD, aka “Dr. Glaucomflecken”

THURSDAY, MARCH 23TH, 2022 AT 8:00 AM EDT

Will Flanary is an ophthalmologist and part time comedian who moonlights in his free time as “Dr. Glaucomflecken,” a social media personality who creates medical-themed comedy shorts to an audience of over 3 million across social media. His humor has been shaped by the tribulations of med school and residency, but also by his experiences as a patient.

Will is a 2-time testicular cancer survivor as well as a survivor of cardiac arrest, saved by his intrepid wife and her timely CPR. Initially used as a creative outlet to cope with these health challenges, Will’s comedy has evolved over time to incorporate biting satire of the US health care system, academic publishing, and interpersonal conflicts pervasive in the medical system. He is a frequent keynote speaker who encourages medical audiences to embrace humor in everyday life.

Conference Co-Chairs

Community Oncology Conference Co-Chair Fred Divers, MD

Stephen “Fred” Divers, MD

Genesis Cancer & Blood Institute & American Oncology Network

VIEW PROFILE

Stephen “Fred” Divers, MD

About the Co-Chair

Dr. Divers received his medical degree from Louisiana State University where he was a selected as a member of Alpha Omega Alpha. He completed his residency in Internal Medicine at the University of North Carolina at Chapel Hill. During his tenure there, he was named the Outstanding Resident all three years and received the Chairman’s award for his performance in medicine. He completed a dual fellowship in Hematology and Oncology at University of Alabama, where he conducted clinical trials in combined modality therapy for lung cancer and translational research with gene arrays and immune checkpoint therapy. He was honored as the Outstanding Clinical Fellow and Outstanding Research Fellow while in Alabama. Following completion of his training, he joined Genesis Cancer Center in Hot Springs, Arkansas in 2004 as a practicing physician. Locally, he served as Chief of Staff for CHI ST Vincent hospital and Chairman of the Cancer committee. He was instrumental in founding the CPAN chapter for patient advocacy in in Arkansas. He has continued clinical research in the private setting, publishing data from multiple trials involved with cell free DNA sequencing and therapeutics. He continues to serve as a member of the ION advisory panel and on the Community Oncology Alliance as an active board member and Co-Chair for the annual conference. He and his partners joined American Oncology Network in 2018 with a group from Louisiana as the founding practices. He is currently Chairman of the Advisory board for AON, and remains passionate about the success of community oncology.

Kathy Oubre

Pontchartrain Cancer Center

VIEW PROFILE

Kathy Oubre

About the Co-Chair

Kathy Oubre is the CEO of Pontchartrain Cancer Center in Louisiana.

Kathy is a board member of the Community Oncology Alliance and co-chairs the Biosimilars committee and serves on their Government Affairs committee. Kathy chairs the NCODA Oncology Institute. She also serves on the Strategic Advisory committee and Leadership Council for Flatiron Health. Kathy is a member of ACCC and serves on their Oral Oncolytics Advisory committee. She is a member of the national MGMA and serves on their government affairs group. She is also the past president for the Louisiana MGMA and chairs their government affairs committee. Kathy also serves on the editorial boards for The Center for Biosimilars and Evidence-Based Oncology.

Community Oncology Conference Co-Chair Debra Patt, MD

Debra Patt, MD, PhD, MBA

Texas Oncology & US Oncology

VIEW PROFILE

Debra Patt, MD, PhD, MBA

About the Co-Chair

Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer and research in healthcare informatics.

Dr. Patt has responsibility for breast cancer research in Austin and leads our multidisciplinary tumor boards for breast cancer.

As an expert in healthcare policy, she has testified before Congress to protect access to care for Medicare beneficiaries. She chairs the Council on Legislation for the Texas Medical Association and works to formulate responsible healthcare policy that improves the health of Texans. She serves as the Editor in Chief of the Journal of Clinical Oncology Clinical Cancer Informatics, and drives engagement in clinical informatics solutions to enhance healthcare. Her research is in clinical decision support, predictive analytics, telemedicine, HEOR, tools for patient symptom management and quality improvement.

Within Texas Oncology, she serves on the payer relations, marketing, telemedicine, strategy, policy, management executive, marketing, and revenue cycle committees.

She is the past-chair of ASCO’s clinical practice committee and served on ASCO’s nominating committee for the ASCO Board and the Conquer Cancer Foundation as well as the health IT work group, EHR, technology, and data requirements workgroup, and guidelines committees.

Dr. Patt serves as the President of the Texas Society of Clinical Oncology, the Vice President for the Community Oncology Alliance and serves locally on the Austin Healthcare Council, Shivers Board, and formerly on the board of Komen and the Breast Cancer Resource Center.

She lectures medical students and is a clinical Professor at Dell Medical School at The University of Texas at Austin.

Alti Rahman MHA/MBA, CSSBB

Oncology Consultants

VIEW PROFILE

Alti Rahman MHA, MBA, CSSBB

Community Oncology Conference Co-Chair Alti Rahman, MD

About the Co-Chair

Alti is the Practice Administrator for Oncology Consultants. He holds a dual Masters degree in Healthcare and Business Administration from the University of Houston and is a Certified Six Sigma Black Belt (CSSBB).

Oncology Consultant’s has 14 Medical Oncology offices. Ancillary services include 2 Radiation Oncology office, 2 Diagnostic Imaging centers, 3 Retail Pharmacy’s, and Clinical Research programs all supported by a central administrative office.

Alti holds additional roles including: Six Sigma course instructor for Medical Group Management Association (MGMA), Board Member of COA (Community Oncology Alliance) and Co-Chair of the COA Administrator Network (CAN), Treasurer for the National Cancer Care Alliance (NCCA), Steering Committee Member for McKesson Specialty Health, Board Member of the Oncology Circle Advisory, and President of the Coalition of Hematology and Oncology Practices (CHOP).

Community Oncology Conference 2023 Schleicher Co-Chair

Stephen Schleicher, MD, MBA

Tennessee Oncology

VIEW PROFILE

Stephen Schleicher, MD, MBA

Community Oncology Conference Co-Chair Stephen Schleicher, MD

About the Co-Chair

Stephen Schleicher, MD, MBA, was appointed Chief Medical Officer (CMO) of Tennessee Oncology, one of the largest providers of oncology care in the country and the largest in Tennessee, in January 2022. In that role, Dr. Schleicher oversees clinical programs to promote the high-quality, innovative and patient-centered care Tennessee Oncology is known for delivering throughout Tennessee and North Georgia. Prior to this, Stephen served as Medical Director of Value-Based Care across both Tennessee Oncology and OneOncology, a national platform for independent community oncology practices that now includes over 700 oncology providers across the US. Dr. Schleicher received his medical training from Harvard’s Brigham and Women’s Hospital and Memorial Sloan Kettering (MSK) in New York before returning to his hometown of Nashville to join Tennessee Oncology. Dr. Schleicher also spent time as a consultant at McKinsey and Company and received his MBA from Harvard Business School. In addition to his role as CMO for Tennessee Oncology, Dr. Schleicher serves as President of the Tennessee Oncology Practice Society.

Jeffrey Vacirca, MD, FACP

New York Cancer & Blood Specialists & OneOncology

VIEW PROFILE

Jeffrey Vacirca, MD, FACP

Community Oncology Conference Co-Chair Jeffrey Vacirca

About the Co-Chair
Jeffrey Vacirca, MD, FACP is a board-certified hematologist and oncologist, serving as Chief Executive Officer and managing partner at New York Cancer & Blood Specialists. Dr. Vacirca is the immediate past president of the Community Oncology Alliance (COA) and is the medical director for the International Oncology Network (ION), Oncology Network Development at Mt. Sinai Health Network, and for Long Island Aids Care (LIAC). Dr. Vacirca serves on the board of directors of OneOncology, BeyondSpring, and the American Red Cross of Greater New York.

Dr. Vacirca is the founder and chairman of the New York Cancer Foundation, which provides financial assistance to patients undergoing cancer treatment. He is also co-founder and former vice-chairman of Odonate Therapeutics, and director and chair of the Compensation Committee of Spectrum Pharmaceuticals. Dr. Vacirca is the co-founder and president of the National Translational Research group and holds a position for Caris Life Sciences as a Scientific Advisory Board Member. Additionally, he serves as a medical board advisor for Flatiron Health, located in New York City.

Dr. Vacirca has received numerous awards and accolades for his efforts in providing outstanding patient care including Humanitarian of the Year by the American Red Cross, the Theodore Roosevelt Award for outstanding dedication to patient care, and being named in Newsday’s Top Doctors. Additionally, he was honored for his role in enabling I-IAAC staff to bring state of the art HIV testing to New York.

Speakers

After you browse the speakers and faculty, check out the where they all fall in the agenda!

Our Dynamic Keynote Speaker

Our Dynamic Keynote Speaker

Will Flanary, MD, aka “Dr. Glaucomflecken”

Conference Co-Chairs

Connect With Us

Connect With Us